Human γδ T Cell Function Is Impaired Upon Mevalonate Pathway Inhibition
Immunology · 2025
DOI: 10.1111/imm.13931 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2025. Verfasst von Tsz Kin Suen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Mevalonic Acid, Receptors, Antigen, T-Cell, gamma-delta, T-Lymphocytes, Intraepithelial Lymphocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch HEart Foundation/Dutch Cardiovascular Alliance, German Research Foundation (DFG), the grant number is EXC2151/1 ImmunoSensation2-the Immune Sensory System, German Research Foundation (DFG).
Abstract (Originalsprache)
Vδ2 T cells, a predominant human peripheral γδ T cell population, are a promising candidate for the development of immunotherapies against cancer and infected cells. Aminobisphosphonate drugs, such as zoledronate, are commonly used to expand Vδ2 T cells. Yet, such in vitro generated cells have limited efficacy in the clinic. We found that despite inducing excessive proliferation of Vδ2 T cells, zoledronate impaired their effector function and caused the upregulation of the inhibitory receptor TIM3. This effect was due to the inhibition of mevalonate metabolism and dysregulation of downstream biological processes such as protein prenylation and intracellular signalling. In vitro and in vivo inhibition of mevalonate metabolism with zoledronate, statins, and 6‐fluoromevalonate, as well as genetic deficiency of the mevalonate kinase, all resulted in compromised cytokine and cytotoxic molecule production by Vδ2 T cells. Impaired Vδ2 T cell function was accompanied by transcriptome and kinome changes. Our findings reveal the importance of mevalonate metabolism for the proper functioning of Vδ2 T cells. This observation provides important considerations for improving their therapeutic use and has repercussions for patients with statin or aminobisphosphonate treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.
- Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
- PRECISE Platform for Single Cell Genomics and Epigenomics at the DZNE and the University of Bonn, Bonn, Germany.
- Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
- Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
- Institute of Immunology, University of Kiel, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.
ORCID-Profile: Katarzyna Placek
Förderung
- Dutch HEart Foundation/Dutch Cardiovascular Alliance
- German Research Foundation (DFG), the grant number is EXC2151/1 ImmunoSensation2-the Immune Sensory System
- German Research Foundation (DFG)
- European Comission" the program is "Horizon 2020 Research and Innovation Program Under the MArie Sklodowska-Curie
- Dutch Cardiovascular Alliance
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Suen, T. K., Al, B., Ulas, T., Reusch, N., Bahrar, H., Bekkering, S., Bhat, J., Kabelitz, D., Schultze, J. L., van de Veerdonk, F. L., van Lennep, J. R., Riksen, N. P., Joosten, L. A. B., Netea, M. G., & Placek, K. (2025). Human γδ T Cell Function Is Impaired Upon Mevalonate Pathway Inhibition. Immunology. https://doi.org/10.1111/imm.13931
Vancouver
Suen TK, Al B, Ulas T, Reusch N, Bahrar H, Bekkering S, et al. Human γδ T Cell Function Is Impaired Upon Mevalonate Pathway Inhibition. Immunology. 2025. doi:10.1111/imm.13931
BibTeX
@article{Suen2025,
author = {Suen, Tsz Kin and Al, Burcu and Ulas, Thomas and Reusch, Nico and Bahrar, Harsh and Bekkering, Siroon and Bhat, Jaydeep and Kabelitz, Dieter and Schultze, Joachim L and van de Veerdonk, Frank L and van Lennep, Jeanine Roeters and Riksen, Niels P and Joosten, Leo A B and Netea, Mihai G and Placek, Katarzyna},
title = {Human γδ T Cell Function Is Impaired Upon Mevalonate Pathway Inhibition},
journal = {Immunology},
year = {2025},
doi = {10.1111/imm.13931}
}
EUVIMED